MedPath

Levit IV

Brand Name: Levit IV

Generic Name: Levetiracetam

Expiring Soon
Registration Number

DRP-9232-02

Dosage Form

Solution for Injection (IV)

Issuance Date

October 1, 2021

Expiry Date

November 9, 2025

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mg/mL (500 mg/5 mL)
PackagingUSP Type I glass vial sealed with 20 mm grey rubber stopper and blue aluminum flip-off seal x 5 mL Box of 1's

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antiepileptic
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

LevetiracetamActive
Monograph: Levetiracetam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform